AMENDED AND RESTATED Joint venture, research COLLABORATION AND LICENSE AGREEMENTJoint Venture, Research Collaboration and License Agreement • April 10th, 2019 • Arcturus Therapeutics Ltd. • Pharmaceutical preparations • California
Contract Type FiledApril 10th, 2019 Company Industry JurisdictionThis Amended and Restated Joint Venture, Research Collaboration And License Agreement (this “Agreement”) is entered into as of July ___, 2018 (the “Restatement Date”), by and between Providence Therapeutics Inc., a corporation incorporated under the laws of Alberta, Canada having a registered address at MaRS Centre, West Tower, 661 University Ave, Suite 1300, Toronto, Ontario, Canada (“Providence”), and Arcturus Therapeutics, Inc., a Delaware corporation with its principal place of business located at 10628 Science Center Drive, Suite 250, CA 92121, USA (“Arcturus”). Arcturus and Providence are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDED AND RESTATED Joint venture, research COLLABORATION AND LICENSE AGREEMENTJoint Venture, Research Collaboration and License Agreement • March 18th, 2019 • Arcturus Therapeutics Ltd. • Pharmaceutical preparations • California
Contract Type FiledMarch 18th, 2019 Company Industry JurisdictionThis Amended and Restated Joint Venture, Research Collaboration And License Agreement (this “Agreement”) is entered into as of July ___, 2018 (the “Restatement Date”), by and between Providence Therapeutics Inc., a corporation incorporated under the laws of Alberta, Canada having a registered address at MaRS Centre, West Tower, 661 University Ave, Suite 1300, Toronto, Ontario, Canada (“Providence”), and Arcturus Therapeutics, Inc., a Delaware corporation with its principal place of business located at 10628 Science Center Drive, Suite 250, CA 92121, USA (“Arcturus”). Arcturus and Providence are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.